RxDoctor Payments Data

Kelley Ross

Family · Dickson, TNNPI 1265741946

Payments from drug & device makers

$8,420in general payments, 2019–2025

Across 565 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$890
  • Lilly USA, LLC$738
  • Pfizer$675
  • AstraZeneca$672
  • Bayer$485
  • plus $3K from 42 others

What the payments were for

  • Food & beverage$8,27798%
  • Education$1432%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,420 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$242,256
Medicare patients
446
Services billed
19,067

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol315$218,140
EliquisApixaban226$171,406
JardianceEmpagliflozin189$165,261
OzempicSemaglutide157$157,991
MounjaroTirzepatide90$104,476
JanuviaSitagliptin Phosphate95$81,615
Trelegy ElliptaFluticasone/Umeclidin/Vilanter110$76,187
RybelsusSemaglutide50$72,103
Tresiba Flextouch U-100Insulin Degludec57$39,932
TrulicityDulaglutide42$39,613
XareltoRivaroxaban51$35,797
EntrestoSacubitril/Valsartan36$29,840
TradjentaLinagliptin30$28,162
LinzessLinaclotide37$27,379
MyrbetriqMirabegron30$23,711

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort$672$244,874368 claims
Novo NordiskOzempic, Rybelsus$1,730$230,094207 claims
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$65$200,828233 claims
PfizerEliquis$675$171,406226 claims
Lilly USA, LLCMounjaro, Trulicity$738$144,089132 claims
MerckJanuvia, Janumet$19$98,770118 claims
GSKTrelegy Ellipta, Breo Ellipta$115$87,266130 claims
AbbVieLinzess, Vraylar, Synthroid$890$51,716128 claims
Johnson & JohnsonXarelto$141$35,79751 claims
NovartisEntresto$421$29,84036 claims
Astellas Pharma US IncMyrbetriq, Veozah$210$29,65541 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$104$11,02624 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,706 family providers in Tennessee.

Other family in Dickson

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →